My podcast guest Stephanie Buxhoeveden was diagnosed with MS when she was 25 years old, working as a neurosurgical ICU nurse. Today, Stephanie is a board-certified Multiple Sclerosis Nurse, she is a Nurse Practitioner and she is the Co-Director of the MS Comprehensive Care Center where she has also been a patient. Stephanie will share some of her experiences and observations from the dual perspective of someone who is a medical specialist who treats patients with MS, and also someone who lives with MS. We're also talking about the results of the very first clinical trial to demonstrate a slowing in the progression of disability in secondary progressive MS. We'll tell you about a new Canadian study that shows a clear connection between depression and physical disability in MS. And we'll talk about the kind of information that California's new prescription drug price transparency bill is revealing. ____________
:18 MS Awareness -- It's A 12-Month Campaign
3:01 New Drug Slows Disability Progression in Secondary Progressive MS
4:09 Study Shows Depression Impacts MS Physical Disability
6:42 Drug Price Transparency Law in California Begins to Reveal Real Information
8:49 Interview with Stephanie Buxhoeveden
___________
LINKSIf your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com
Articles & Videos by Stephanie Buxhoeveden
GPS For Your MS: Initiating Your Wellness Journey
Emergency Preparedness
Facing the Emotional Symptoms of MS Together
TedX Talk: Thriving In The Face of Adversity
MS Path 2 Care
___________
For more RealTalk MS, follow us on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 26 Guests: Stephanie Buxhoeveden, MSCN, FN-BC, MS Activist Hosted By: Jon Strum
Tags: MS, multiple sclerosis, Stephanie Buxhoeveden, Siponimod, MS and depression, MS prescription drug prices, prescription drug price transparency, MS podcast, RealTalk MS